TUCAN/CARDINAL/CARD8 and apoptosis resistance in non-small cell lung cancer cells

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Checinska, Agnieszka ^a   Giaccone, Giuseppe ^a   Hoogeland, Bas S J ^a   Ferreira, Carlos G ^a,b   Rodriguez, Jose A ^a   Kruyt, Frank A E ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CASPASE 9; CASPASE 9 INHIBITOR; CASPASE RECRUITMENT DOMAIN PROTEIN 8; CELL EXTRACT; CISPLATIN; CYTOCHROME C; DEOXYADENOSINE TRIPHOSPHATE; ETOPOSIDE; PROCASPASE 9; RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL LYSATE; CELL VIABILITY; CHEMOSENSITIVITY; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PLASMID; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STUDENT T TEST; TRANSLATION REGULATION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, NON-SMALL-CELL LUNG; CARD SIGNALING ADAPTOR PROTEINS; CASPASE 9; CASPASE INHIBITORS; CASPASES; CISPLATIN; CYTOCHROMES C; DEOXYADENINE NUCLEOTIDES; DOWN-REGULATION; GENE EXPRESSION PROFILING; HUMANS; NEOPLASM PROTEINS; PROTEIN BINDING; RNA INTERFERENCE; TUMOR CELLS, CULTURED;

EID: 33747307975     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-166     Document Type: Article

References (30)

1. Brescia FJ: Lung cancer- a philosophical, ethical and personal perspective. Crit Rev Oncol Hematol 2001, 40:139-148.
2. Schrump DS: Genomic surgery for lung cancer. J Surg Res 2004, 117:107-113.
3. Fennell DA: Caspase regulation in non-small cell lung cancer and its potential for therapeutic exploitation. Clin Cancer Res 2005, 1:2097-2105.
4. Cohen GM: Caspases: the executioners of apoptosis. Biochem J 1997, 15:1-16.
5. Mesner PW Jr, Budihardjo II, Kaufmann SH: Chemotherapy-induced apoptosis. Adv Pharmacol 1997, 41:461-499.
6. Kaufmann SH, Vaux DL: Alterations in the apoptotic machinery and their potential role in anticancer drug resistance. Oncogene 2003, 22:7414-7430.
7. Earnshaw WC, Martins LM, Kaufmann SH: Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999, 68:383-424.
8. Hengartner M: The biochemistry of apoptosis. Nature 2000, 407:770-776.
9. Zou H, Li Y, Liu X, Wang X: An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 1999, 27:11549-11556.
10. Salvesen GS, Duckett CS: IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 2002, 3:401-410.
11. Pathan N, Marusawa H, Krajewska M, Matsuzawa S, Kim H, Okada K, Torii S, Kitada S, Krajewski S, Welsh K, Pio F, Godzik A, Reed JC: TUCAN, an antiapoptotic caspase-associated recruitment domain family protein overexpressed in cancer. J Biol Chem 2001, 276:32220-32229.
12. Yamamoto M, Torigoe T, Kamiguchi K, Hirohashi Y, Nakanishi K, Nabeta C, Asanuma H, Tsuruma T, Sato T, Hata F, Ohmura T, Yamaguchi K, Kurotaki T, Hirata K, Sato N: A novel isoform of TUCAN is overexpressed in human cancer tissues and suppresses both caspase-8- and caspase-9-mediated apoptosis. Cancer Res 2005, 65:8706-14.
13. Razmara M, Srinivasula SM, Wang L, Poyet JL, Geddes, DiStefano PS, Bertin J, Alnemri ES: CARD-8 protein, a new CARD family member that regulates caspase-1 activation and apoptosis. J Biol Chem 2003, 277:13952-13968.
14. Bouchier-Hayes L, Conroy H, Egan H, Adrain C, Creagh EM, MacFarlane M, Martin SJ, et al.: CARDINAL, a novel caspase recruitment domain protein, is an inhibitor of multiple NF-kappa B activation pathways. J Biol Chem 2001, 276:44069-44077.
15. Ferreira CG, Span SW, Peters GJ, Kruyt FA, Giaccone G: Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria -controlled manner in the non-small cell lung cancer cell line NCI-H460. Cancer Res 2000, 60:7133-7141.
16. Yang L, Mashima T, Sato S, Mochizuki M, Sakamoto H, Yamori T, Oh-Hara T, Tsuruo T, et al.: Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide. Cancer Res 2003, 63:831-837.
17. Krepela E, Prochazka J, Liu X, Fiala P, Kinkor Z: Increased expression of Apaf-1 and procaspase-3 and the functionality of intrinsic apoptosis apparatus in non-small cell lung carcinoma. Biol Chem 2004, 385:153-168.
18. Kruyt FA, Checinska, Giaccone G, Ferreira CG: Correspondence re: L. Yang et al., Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide. Cancer Res 2003, 63:831-837.
19. Prikhod'ko GG, Prikhod'ko EA, Pletnev AG, Cohen JI: Langat flavivirus protease NS3 binds caspase-8 and induces apoptosis. J Virol 2002, 76:5701-5710.
20. Stilo R, Leonardi A, Formisano L, Di Jeso B, Vito P, Liguoro D: TUCAN/ CARDINAL and DRAL participate in a common pathway for modulation of NF-kappaB activation. FEBS Lett 2002, 521:165-179.
21. Benedict MA, Hu Y, Inohara N, Núñez G: Expression andfunctional analysis of Apaf-1 isoforms extra WD-40 repeatis requiredfor cytochrome c binding and regulated activation of procaspase-9. J Biol Chem 2000, 275:8461-8468.
22. Duan H, Orth K, Chinnaiyan AM, Porier GG, Froelich CJ, He WW, Dixit VM: ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease B. J Biol Chem 1996, 271:16720-16724.
23. Brummelkamp TR, Bernards R, Agami R: Stable supression of tumorigenicity by virus-mediate RNA intereference. Cancer Cell 2002, 2:243-247.
24. Janmaat ML, Kruyt FA, Rodriguez JA, Giaccone G: Response to epidermal growth factor receptori inhibitors in Non-Small Cell Lung cancer cells limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regulated kinase or Akt Kinase pathways. Clin Cancer Res 2003, 6:2316-2326.
25. Hill MM, Adrain C, Duriez PJ, Creagh EM, Martin SJ: Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosome. EMBO J 2004, 19(23):2134-2145.
26. Kruyt FA, Abou-Zahr F, Mok H, Youssoufian H: Resistance to mitomycin C requires direct interaction between the Fanconi anemia proteins FANCA and FANCG in the nucleus through an arginine-rich domain. J Biol Chem 1999, 274:34212-34218.
27. Zou H, Yang R, Hao J, Wang J, Sun C, Fesik SW, Wu JC, Tomaselli KJ, Armstrong RC: Regulation of the Apaf-1/caspase-9 apoptosome by caspase-3 and XIAP. J Biol Chem 2003, 278:8091-8098.
28. Joseph B, Ekedahl J, Lewensohn R, Marchetti P, Formstecher P, Zhivotovsky B: Defective caspase-3 relocalization in non-small cell lung carcinoma. Oncogene 2001, 20:2877-2888.
29. Damiano JS, Reed JC: CARD proteins as therapeutic targets in cancer. Curr Drug Targets 2004, 5:367-374.
30. Bouchier-Hayes L, Martin SJ: CARD games in apoptosis and immunity. EMBO Rep 2002, 3:616-621.